-LHG OTSUKA PHARMACEUTICAL CO., LTD. v. SANDOZ, INC., No. 3:2007cv01000 - Document 391 (D.N.J. 2010)

Court Description: ORDER that the 385 Memorandum Opinion filed in this action on November 15, 2010 and 386 Order & Final Judgment filed in this action on November 15, 2010 be amended to correct certain typographical errors brought to the Court's attention; an Amended Memorandum Opinion and an Amended Order & Final Judgment shall be filed separately, reflecting the changes above and superseding the Memorandum Opinion and Order & Final Judgment of November 15, 2010. Signed by Judge Mary L. Cooper on 12/14/2010. (mmh)

Download PDF
-LHG OTSUKA PHARMACEUTICAL CO., LTD. v. SANDOZ, INC. Doc. 391 UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY OTSUKA PHARMACEUTICAL CO., LTD., Plaintiff, v. SANDOZ, INC., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD., BARR LABORATORIES, INC., BARR PHARMACEUTICALS, INC., APOTEX INC., APOTEX CORP., SUN PHARMACEUTICAL INDUSTRIES, LTD., SYNTHON HOLDING BV, SYNTHON BV, SYNTHON PHARMACEUTICALS, INC., and SYNTHON LABORATORIES, INC., Defendants. : : : : : : : : : : : : : : : : : : : : : : Consolidated Civil Action No. 3:07-cv-01000 (MLC) ORDER AMENDING MEMORANDUM OPINION AND ORDER & FINAL JUDGMENT The Court entered a Memorandum Opinion and Order & Final Judgment in this action on November 15, 2010. (Dkt. entry nos. 385, 386.) Plaintiff’s counsel subsequently brought several typographical errors to the Court’s attention. (Undocketed Letter from Paul Browning to the Court, dated November 18, 2010.) No party has objected to any of the suggested corrections. For good cause appearing: IT IS HEREBY ORDERED that the Memorandum Opinion filed in this action on November 15, 2010, be amended as follows: a) On page 2, delete “U.S. Patent No. 5,000,528” and replace with “U.S. Patent No. 5,006,528” Dockets.Justia.com b) On page 10, footnote 5, line 1, delete “butoxy linker” and replace with “propoxy linker” c) On page 11, line 8, delete “DTX 121 at OPC 1554” and replace with “DTX 121 at OPC 1274” d) On page 15, line 2, delete “butoxy analog” and replace with “propoxy analog” e) On page 24, footnote 14, line 1, delete “butoxy-linked” and replace with “propoxy-linked” f) On page 30, line 6, delete the second “not” on that line g) On page 47, line 6, change “psychotic” to “antipsychotic”; and IT IS FURTHER ORDERED that the Order & Final Judgment filed in this action on November 15, 2010, be amended as follows: a) change “U.S. Patent No. 5,000,528” to “ U.S. Patent No. 5,006,528”; and IT IS FURTHER ORDERED that an Amended Memorandum Opinion and an Amended Order & Final Judgment shall be filed separately, reflecting the changes above and superseding the Memorandum Opinion and Order & Final Judgment of November 15, 2010. s/Mary L. Cooper MARY L. COOPER United States District Judge 2

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.